Letters Balancing benefits and harms in health care: Technology to collect and share information about harms already exists BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7463.457 (Published 19 August 2004) Cite this as: BMJ 2004;329:457 Article Related content Metrics Responses Peer review Related articles Education And Debate Detection, verification, and quantification of adverse drug reactions Published: 01 July 2004; BMJ 329 doi:10.1136/bmj.329.7456.44 Clinical Review Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs Published: 01 July 2004; BMJ 329 doi:10.1136/bmj.329.7456.31 Editorial Collecting and sharing information about harms Published: 01 July 2004; BMJ 329 doi:10.1136/bmj.329.7456.6 See more Doctors, their leaders, and the drug policy debate BMJ November 14, 2016, 355 i6087; DOI: https://doi.org/10.1136/bmj.i6087 Revisiting the drug interaction between tamoxifen and SSRI antidepressants BMJ September 30, 2016, 354 i5309; DOI: https://doi.org/10.1136/bmj.i5309 Cold feet BMJ September 05, 2016, 354 i4584; DOI: https://doi.org/10.1136/bmj.i4584 US drug labels to warn of risks of combining opioids and benzodiazepines BMJ September 02, 2016, 354 i4784; DOI: https://doi.org/10.1136/bmj.i4784 US states that allow medical marijuana see drop in prescriptions for other drugs, study finds BMJ July 14, 2016, 354 i3942; DOI: https://doi.org/10.1136/bmj.i3942
